# FDA Inspection 1168773 - George Hartley Freeman, M.D. - April 22, 2022

Source: https://www.keypedia.com/records/fda_inspections/george-hartley-freeman-md/cd2876be-bba9-4f6d-b58c-2fb87d20d90a
Source feed: FDA_Inspections

> FDA Inspection 1168773 for George Hartley Freeman, M.D. on April 22, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1168773
- Company Name: George Hartley Freeman, M.D.
- Inspection Date: 2022-04-22
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1290506 - 2025-10-09](https://www.keypedia.com/records/fda_inspections/george-hartley-freeman-md/a567e411-ec2f-4456-8aad-296e20389d6d)
- [FDA Inspection 1290506 - 2025-10-09](https://www.keypedia.com/records/fda_inspections/george-hartley-freeman-md/1ee40c64-6fc5-4b77-b072-ab357f0610ef)
- [FDA Inspection 1141195 - 2021-04-23](https://www.keypedia.com/records/fda_inspections/george-hartley-freeman-md/f37886c5-a8d8-41c5-8a86-bddba4d24c82)
- [FDA Inspection 1141195 - 2021-04-23](https://www.keypedia.com/records/fda_inspections/george-hartley-freeman-md/b18ab296-2a63-4a6c-a647-df13fcb1adc9)

Company: https://www.keypedia.com/companies/george-hartley-freeman-md/576c1b16-251a-4796-849c-26f22e351929

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c